Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MAVACAMTEN for Cardiomyopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where MAVACAMTEN was used for Cardiomyopathy.

Most Reported Side Effects for MAVACAMTEN

Side Effect Reports % Deaths Hosp.
Product dose omission issue 231 7.1% 0 15
Atrial fibrillation 224 6.9% 7 56
Fatigue 204 6.3% 0 17
Dyspnoea 195 6.0% 0 29
Dizziness 187 5.8% 0 33
Product use issue 180 5.5% 0 7
Ejection fraction decreased 115 3.5% 3 26
Off label use 113 3.5% 1 10
Headache 106 3.3% 0 12
Nasopharyngitis 102 3.1% 0 3
Adverse event 100 3.1% 0 17
Palpitations 83 2.6% 0 10
Chest pain 79 2.4% 0 13
Weight increased 78 2.4% 0 6
Cough 76 2.3% 0 4

Other Indications for MAVACAMTEN

Hypertrophic cardiomyopathy (2,708) Product used for unknown indication (502) Cardiac disorder (6)

Other Drugs Used for Cardiomyopathy

SACUBITRIL\VALSARTAN (527) FUROSEMIDE (255) TAFAMIDIS (163) SPIRONOLACTONE (121) BISOPROLOL (114) TAFAMIDIS MEGLUMINE (102) AMIODARONE (92) CARVEDILOL (88) METOPROLOL (87) LISINOPRIL (59)

Related Pages

MAVACAMTEN Full Profile All Cardiomyopathy Drugs MAVACAMTEN Demographics MAVACAMTEN Timeline